Copeland, I; Galipeau, J; Roback, J; Waller, E
Elate Ocular™ is designed to treat chronic dry, which is a common eye disease, is a leading cause of patient visits to eye practitioners. The disease causes dry, burning, gritty, stingy, scratchy sensations and has no cure. Emory inventors developed a technology to treat the disease that uses the regenerative components of platelets that is being developed as a topical biologic ophthalmic drop. Emory licensed this technology to Cambium Medical Technologies in 2014. The FDA authorized Cambium to initiate Phase I trials in fall 2017.